Roche continues to expect tariff impact on diagnostics despite U.S. deal
Source: SeekingAlpha
2026-03-07 11:37:01 ET
More on Roche Holding
- Roche Holding AG (RHHBY) Shareholder/Analyst Presentation
- Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Roche succeeds in mid-stage trial for obesity drug developed with Zealand
- Roche CEO Schinecker wants a bite of the weight loss drugs market
Read the full article on Seeking Alpha
For further details see:
Roche continues to expect tariff impact on diagnostics despite U.S. deal
Roche Holding Ltd ADR
NASDAQ: RHHBY
RHHBY Trading
-3.67% G/L:
$52.925 Last:
482,453 Volume:
$52.32 Open:
RHHBY Latest News
March 09, 2026 02:10:00 am
Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer
RHHBY Stock Data
$361,973,933,704
6,306,832,002
N/A
43
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
